{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:15:28Z","timestamp":1792631728222,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2016A020215142"],"award-info":[{"award-number":["2016A020215142"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009659","name":"Guangzhou Medical University","doi-asserted-by":"publisher","award":["02-408-2304-02079XM"],"award-info":[{"award-number":["02-408-2304-02079XM"]}],"id":[{"id":"10.13039\/100009659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.heliyon.2024.e26960","type":"journal-article","created":{"date-parts":[[2024,2,25]],"date-time":"2024-02-25T18:01:46Z","timestamp":1708884106000},"page":"e26960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Decreased plasma miR-140-3p is associated with coronary artery disease"],"prefix":"10.1016","volume":"10","author":[{"given":"Pei","family":"Mo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Wei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6075-0466","authenticated-orcid":false,"given":"Benrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e26960_bib1","doi-asserted-by":"crossref","first-page":"16812","DOI":"10.1002\/jcp.28350","article-title":"A review on coronary artery disease, its risk factors, and therapeutics","volume":"234","author":"Malakar","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.heliyon.2024.e26960_bib2","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1007\/s11033-022-07196-5","article-title":"The association of plasma levels of miR-146a, miR-27a, miR-34a, and miR-149 with coronary artery disease","volume":"49","author":"Hosseinpor","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.heliyon.2024.e26960_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2020.1795365","article-title":"Systematic review of extracellular vesicle-based treatments for lung injury: are EVs a potential therapy for COVID-19?","volume":"9","author":"Khalaj","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.heliyon.2024.e26960_bib4","first-page":"1184","article-title":"Correlation of miR-24-3p and miR-595 expression with CCL3, CCL4, IL1-beta, TNFalphaIP3, and NF-kappaBIalpha genes in PBMCs of patients with coronary artery disease","volume":"21","author":"Kazemian","year":"2022","journal-title":"EXCLI. J."},{"key":"10.1016\/j.heliyon.2024.e26960_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/bs.pmbts.2016.12.013","article-title":"MicroRNAs as peripheral biomarkers in aging and age-related diseases","volume":"146","author":"Kumar","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.heliyon.2024.e26960_bib6","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1113\/JP270557","article-title":"MicroRNAs in cardiovascular ageing","volume":"594","author":"Seeger","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.heliyon.2024.e26960_bib7","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/cvr\/cvz302","article-title":"Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease","volume":"116","author":"Kaur","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.heliyon.2024.e26960_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/iub.2421","article-title":"Expression levels of miR-27a, miR-329, ABCA1, and ABCG1 genes in peripheral blood mononuclear cells and their correlation with serum levels of oxidative stress and hs-CRP in the patients with coronary artery disease","volume":"73","author":"Rafiei","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.heliyon.2024.e26960_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.genrep.2022.101578","article-title":"Investigating the predictive value of microRNA21 as a biomarker in induced myocardial infarction animal model","volume":"27","author":"Hosseini","year":"2022","journal-title":"Gene Reports"},{"key":"10.1016\/j.heliyon.2024.e26960_bib10","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1161\/ATVBAHA.111.226696","article-title":"Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?","volume":"31","author":"Fichtlscherer","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.heliyon.2024.e26960_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ejhf.244","article-title":"MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure","volume":"17","author":"Watson","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.heliyon.2024.e26960_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1515\/cclm-2016-0576","article-title":"microRNAs in cardiovascular disease - clinical application","volume":"55","author":"Schulte","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.heliyon.2024.e26960_bib13","first-page":"403","article-title":"MicroRNAs: a role in the development of cardiovascular disease, the possibility for clinical application, Klin","volume":"63","author":"Velikiy","year":"2018","journal-title":"Lab. Diagn."},{"key":"10.1016\/j.heliyon.2024.e26960_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/aps.2018.30","article-title":"miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges","volume":"39","author":"Zhou","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.heliyon.2024.e26960_bib15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/heartjnl-2013-305402","article-title":"MicroRNAs in cardiovascular disease: an introduction for clinicians","volume":"101","author":"Romaine","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.heliyon.2024.e26960_bib16","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","article-title":"MicroRNA regulation of atherosclerosis","volume":"118","author":"Feinberg","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.heliyon.2024.e26960_bib17","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1007\/s11033-021-06441-7","article-title":"Serum levels of IL-32 in patients with coronary artery disease and its relationship with the serum levels of IL-6 and TNF-alpha","volume":"48","author":"Mohammad-Rezaei","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.heliyon.2024.e26960_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.plefa.2021.102324","article-title":"The association between a Fatty Acid Binding Protein 1 (FABP1) gene polymorphism and serum lipid abnormalities in the MASHAD cohort study","volume":"172","author":"Valizadeh","year":"2021","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.heliyon.2024.e26960_bib19","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1136\/jim-2021-002134","article-title":"Serum levels of IL-37 and correlation with inflammatory cytokines and clinical outcomes in patients with coronary artery disease","volume":"70","author":"Rafiei","year":"2022","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.heliyon.2024.e26960_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1159\/000525845","article-title":"The serum levels of IL-36 in patients with coronary artery disease and their correlation with the serum levels of IL-32, IL-6, TNF-alpha, and oxidative stress","volume":"183","author":"Kazemian","year":"2022","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.heliyon.2024.e26960_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/joim.12822","article-title":"eDoctor: machine learning and the future of medicine","volume":"284","author":"Handelman","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.heliyon.2024.e26960_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2020.11.030","article-title":"Machine learning and the future of cardiovascular care: JACC state-of-the-art review","volume":"77","author":"Quer","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e26960_bib23","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI131838","article-title":"Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease","volume":"130","author":"Poss","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2024.e26960_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13073-019-0705-z","article-title":"An unsupervised learning approach to identify novel signatures of health and disease from multimodal data","volume":"12","author":"Shomorony","year":"2020","journal-title":"Genome Med."},{"key":"10.1016\/j.heliyon.2024.e26960_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.31083\/j.fbl2707211","article-title":"A machine learning model based on genetic and traditional cardiovascular risk factors to predict premature coronary artery disease","volume":"27","author":"Liu","year":"2022","journal-title":"Front. Biosci."},{"key":"10.1016\/j.heliyon.2024.e26960_bib26","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/biof.1783","article-title":"A pilot study of the effects of crocin on high-density lipoprotein cholesterol uptake capacity in patients with metabolic syndrome: a randomized clinical trial","volume":"47","author":"Saberi-Karimian","year":"2021","journal-title":"Biofactors"},{"key":"10.1016\/j.heliyon.2024.e26960_bib27","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1093\/nar\/gkn725","article-title":"High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA","volume":"36","author":"Mestdagh","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2024.e26960_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ab.2009.12.008","article-title":"Selection of appropriate reference genes for gene expression studies by quantitative real-time polymerase chain reaction in cucumber","volume":"399","author":"Wan","year":"2010","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.heliyon.2024.e26960_bib29","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","article-title":"Reporting and interpreting decision curve analysis: a guide for Investigators","volume":"74","author":"Van Calster","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.heliyon.2024.e26960_bib30","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1007\/s10753-020-01257-2","article-title":"KCNQ1OT1 exacerbates ischemia-reperfusion injury through targeted inhibition of miR-140-3P","volume":"43","author":"Yi","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.heliyon.2024.e26960_bib31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1248\/bpb.b19-00959","article-title":"MiR-140-3p ameliorates the progression of osteoarthritis via targeting CXCR4","volume":"43","author":"Ren","year":"2020","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.heliyon.2024.e26960_bib32","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/art.39446","article-title":"Amelioration of experimental autoimmune arthritis through targeting of synovial fibroblasts by intraarticular delivery of MicroRNAs 140-3p and 140-5p","volume":"68","author":"Peng","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.heliyon.2024.e26960_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13148-017-0428-1","article-title":"Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes","volume":"9","author":"Ntoumou","year":"2017","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.heliyon.2024.e26960_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jdiacomp.2019.02.001","article-title":"Hyperglycemia inhibition of endothelial miR-140-3p mediates angiogenic dysfunction in diabetes mellitus","volume":"33","author":"Wang","year":"2019","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.heliyon.2024.e26960_bib35","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.5551\/jat.44024","article-title":"MiR-140-3p is involved in in-stent restenosis by targeting C-myb and BCL-2 in peripheral artery disease","volume":"25","author":"Zhu","year":"2018","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.heliyon.2024.e26960_bib36","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1042\/CS20100043","article-title":"Gene expression profiling in whole blood of patients with coronary artery disease","volume":"119","author":"Taurino","year":"2010","journal-title":"Clin. Sci. (Lond)."},{"key":"10.1016\/j.heliyon.2024.e26960_bib37","first-page":"516","article-title":"Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study","volume":"38","author":"Karakas","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.heliyon.2024.e26960_bib38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/MED.0000000000000315","article-title":"The HDL cholesterol\/apolipoprotein A-I ratio: an indicator of cardiovascular disease","volume":"24","author":"Rhee","year":"2017","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.heliyon.2024.e26960_bib39","doi-asserted-by":"crossref","first-page":"15L","DOI":"10.1016\/S0002-9149(00)01463-6","article-title":"Dyslipidemia, gender, and the role of high-density lipoprotein cholesterol: implications for therapy","volume":"86","author":"Legato","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e26960_bib40","first-page":"733","article-title":"Cardiovascular risk factors and prevention: a perspective from developing countries","volume":"37","author":"Teo","year":"2021","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.heliyon.2024.e26960_bib41","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2021.15187","article-title":"Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999-2018","volume":"326","author":"He","year":"2021","journal-title":"JAMA"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024029918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024029918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:47:19Z","timestamp":1769046439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024029918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2405844024029918"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26960","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased plasma miR-140-3p is associated with coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e26960"}}